Global Autosampler Market Grows Steadily at a CAGR of 6.7%

Introduction

A typical autosampler is a device connected to an analytical instrument and supplies periodic samples for analysis. Autosamplers facilitate significant productivity, precision, and accuracy increases in various analytical scenarios and are widely utilized in laboratories. Liquid injection, static and dynamic headspace, purge and capture, and fraction extraction are typical applications.

Various devices, including water analyzers, liquid and gas chromatography devices, and titrators, use autosamplers in various clinical and scientific applications. Autosamplers facilitate significant productivity, precision, and accuracy increases in various analytical scenarios and are widely utilized in laboratories.

Market Dynamics

Increasing Number of Research Studies Drives the Global Market

The demand for autosamplers is increasing as biological and chemical research advances. The number of research studies and innovations is rising rapidly to satisfy the rising demand in industries such as life sciences, food and beverages, and chemicals. The conclusion of research in these industries is the laboratory testing and transfer of novel products to the manufacturing level.

According to a report by Research America, between 2013 and 2016, investments in medical health R&D increased by 20.6%. In 2016, the United States spent USD 171.8 billion on medical and health research and development. This R&D expenditure was supported by healthcare service companies, medical technology developers, and biopharmaceutical developers. Therefore, rising investments and expanding R&D-related activities are anticipated to fuel market expansion.

Increasing Use of Automation in Laboratories Creates Tremendous Opportunities

A limited number of specialty labs (primarily high-volume clinical or biomedical applications) are currently developing a concept known as total lab automation (TLA), which consists of specimen sorters, automation systems, robotic transporters, and analytical analyzers. These systems can have a significant effect on automating the testing and increasing the lab's productivity by eliminating the majority of manual tasks. These systems are utilized in numerous applications, including large-scale biorepositories, combinatorial chemistry, high-throughput screening, medical diagnostics, clinical and analytical testing, chemical and material processing, etc. Therefore, increasing laboratory automation creates opportunities for market expansion.

Regional Analysis

North America is the most significant global autosampler market shareholder and is estimated to exhibit a CAGR of 6.5% during the forecast period. This is related to the fact that many pharmaceutical and biopharmaceutical companies are involved in R&D. It is also anticipated that an increase in grants granted by governmental agencies, such as the National Institutes of Health (NIH) to support research efforts, will accelerate market expansion. It is projected that local enterprises' high caliber and demonstrated profitability will attract more research funding over the next few years.

In addition, the biopharmaceutical sector is among the biggest sources of funding for research. In order to generate interest in the products, many businesses are investing heavily in sample storage and the development of fresh, potential leads. The extensive spread of the coronavirus has also prompted a surge in the number of companies developing cures and vaccinations, which has helped the market grow.

Key Highlights

• The global autosampler market was valued at USD 33 million in 2022. It is estimated to reach USD 2.38 million by 2031, growing at a CAGR of 6.7% during the forecast period (2023–2031).
• Based on the product, the global autosampler market is bifurcated into autosampler systems and autosampler accessories. The autosampler system segment dominates the global market and is projected to exhibit a CAGR of 6.8% over the forecast period.
• Based on end-users, the global autosampler market is segmented into pharmaceutical and biotechnological companies, chemical industries, research institutes, CROs, and others. The pharmaceutical and biotechnological companies segment owns the highest market share and is estimated to exhibit a CAGR of 6.8% during the forecast period.
• North America is the most significant global autosampler market shareholder and is estimated to exhibit a CAGR of 6.5% during the forecast period.

Competitive Players

1. HTA S.R.L
2. Thermo Fisher Scientific Inc.
3. PerkinElmer Inc.
4. Shimadzu Corporation
5. Avantor Paar
6. Avantor
7. Waters Corporation
8. KNAUER WISSENSCHAFTLICHE GERÄTE GMBH
9. Agilent Technologies Inc.
10. Ellutia.

Recent Developments

• September 2022- HTA announced the release of the HT1200I, the first and only ICP autosampler with closed sample tube support. The support for sealed samples and reagent tubes provides the definitive solution to corrosion and unpleasant odors, which are extremely prevalent problems when working with ICP reagents.
• March 2023- Thermo Fisher Scientific, Inc. TMO introduced the Thermo Scientific iCAP RQplus ICP-MS Analyzer, a new trace elemental analyzer. The analyzer simplifies routine laboratory analyses in environmental, agricultural, pharmaceutical, and industrial settings. The company also introduces the Thermo Scientific iSC-65 Autosampler, which improves the efficiency of the Thermo Scientific iCAP Qnova Series ICP-MS analyzer and the Thermo Scientific iCAP PRO Series ICP-OES.

Segmentation

1. By Product
   1. Autosampler Systems
   2. Autosampler Accessories
2. By End-User
   1. Pharmaceutical and Biotechnological Companies
   2. Chemical Industries
   3. CROs
   4. Others